DB18887InvestigationalProtein Based Therapies
Cagrilintide is under investigation in clinical trial NCT06221969 (A Research Study to See How Much Cagrisema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2...
- Mechanism
- Curator reviewed
Pharmacologically active on Calcitonin receptor
- Also known as
- CagriSema component Cagrilintide · L-Prolinamide, N-(19-carboxy-1-oxononadecyl)-L-γ-glutamyl-L-lysyl-L-cysteinyl-L-asparaginyl-L-threonyl-L-alanyl-L-threonyl-L-cysteinyl-L-alanyl-L-threonyl-L-glutaminyl-L-arginyl-L-leucyl-L-alanyl-L-α-glutamyl-L-phenylalanyl-L-leucyl-L-arginyl-L-histidyl
- Code names
- NNC0174-0833
Resolves to
Compound
Targets
What you can answer from here — as of July 09, 2026
Which drugs share a target with Cagrilintide, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account